Stephen A. Strugnell

Author

Also Known As

S A Strugnell, S Strugnell, S. A. Strugnell, S. STRUGNELL, S. Strugnell, S.A. Strugnell, STEPHEN A. STRUGNELL, Stephen A Strugnell, Stephen A. Strugnell, Stephen Strugnell

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Queen's University OPKO Health (United States)McGill University Shriners Hospitals for Children - Canada NorthShore University HealthSystem

About

Stephen A. Strugnell is an author at Queen's University specializing in pharmacology, biochemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	11	11	462
2	Medicine	10	11	480
3	Health Sciences	6	6	285
4	Natural Sciences	4	4	127
5	Public Health	3	3	121

Stephen A. Strugnell

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Yu-Ding Guo, Stephen A. Strugnell, Donald W. Back, Proceedings of the National Academy of Sciences Lipid PeroxidationP-450 HydroxylatesOxidative StressD AnalogsMitochondrial Biogenesis	1993	173
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease Stuart M. Sprague, Paul W. Crawford, Joel Z. Melnick, American Journal of Nephrology	2016	105
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT <sub>1</sub> receptor antagonist Yan Zhang, Dilip K. Deb, Juan Kong, American Journal of Physiology-Renal Physiology	2009	94
In vitro metabolism of the anti-psoriatic vitamin D analog, calcipotriol, in two cultured human keratinocyte models. S. Masuda, Stephen A. Strugnell, Martin J. Calverley, Journal of Biological Chemistry Chemoprevention StrategyBiochemistryMedicineParathyroid HormoneSide Chain Analog	1994	69
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease Stephen A. Strugnell, Stuart M. Sprague, Akhtar Ashfaq, American Journal of Nephrology	2019	68
1<i>α</i>,24(<i>S</i>)-dihydroxyvitamin D2: a biologically active product of 1<i>α</i>-hydroxyvitamin D2 made in the human hepatoma, Hep3B Stephen A. Strugnell, Valarie Byford, H.L.J. Makin, Biochemical Journal Medicinal ChemistryHuman HepatomaHepatologyBiochemistryAlpha-hydroxyvitamin D2	1995	61
Effects of vitamin D compounds on renal and intestinal Ca2+ transport proteins in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice1 Joost G.J. Hoenderop, Annemiete W.C.M. van der Kemp, Colleen M. Urben, Kidney International PhysiologyDietary IntakeMolecular NutritionPublic HealthMetabolism	2004	57
Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation Martin Petkovich, Joel Z. Melnick, Jay A. White, The Journal of Steroid Biochemistry and Molecular Biology Minimal Cyp24a1 UpregulationNutritionParathyroid DiseaseOsteoporosisTranslational Medicine	2014	45
Different Mechanisms of Hydroxylation Site Selection by Liver and Kidney Cytochrome P450 Species (CYP27 and CYP24) Involved in Vitamin D Metabolism F. Jeffrey Dilworth, Ian M. Scott, Andrew Green, Journal of Biological Chemistry	1995	42
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease Stuart M. Sprague, Stephen A. Strugnell, Charles W. Bishop Expert Review of Endocrinology & Metabolism	2017	34

Page 1